Furthermore, a study in SIRT6-transgenic (SIRT6-Tg) mice demonstrated that Sirt6 alleviated VC in CKD by inhibiting the osteogenic transdifferentiation of VSMCs (155) (Figure 2D). Here, SIRT6 is linked to chronic kidney disease.